glaxosmithkline

WASHINGTON (AP) -- Federal prosecutors said Tuesday they have charged a former GlaxoSmithKline executive with obstructing justice and making false statements in an effort to conceal illegal promotion of a company drug....

(MedPage Today) -- Drugmaker GlaxoSmithKline will pay $750 million to settle civil and criminal charges that the company sold products made in violation of Good Manufacturing Practices, the Justice Department announced Tuesday.

The Bone and Joint Decade (BJD) international initiative and GlaxoSmithKline (GSK) announced the launch of the LIBERATE™ joint pain management programme during the BJD's World Conference in Lund, Sweden...

LONDON (AP) -- GlaxoSmithKline's controversial diabetes pill Avandia should be pulled from the U.K. market because of concerns that the drug can increase the risk of heart attacks, British drug regulators said Monday....

WASHINGTON (AP) -- U.S. health officials urged pediatricians Monday to temporarily stop using one of two vaccines against a leading cause of diarrhea in babies, after discovering that doses of GlaxoSmithKline's Rotarix were contaminated with bits of an apparently benign pig virus....

NEW YORK (AP) -- Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals now are pursuing....

Canadian health officials are continuing to investigate a spike in anaphylaxis associated with one batch of the country's H1N1 vaccine, made by GlaxoSmithKline.

LONDON (AP) -- Canadian doctors have been advised not to use a batch of 170,000 doses of swine flu vaccine while authorities investigate reports of allergic reactions among recipients, drug maker GlaxoSmithKline PLC said Tuesday....

LONDON (AP) -- Pharmaceuticals company GlaxoSmithKline PLC said Tuesday it has advised medical staff in Canada to not use one batch of swine flu vaccines in case they trigger life-threatening allergies....

WASHINGTON (MedPage Today) -- The FDA said today that GlaxoSmithKline has reported the death of an influenza patient treated with nebulized Relenza (zanamivir).